WALDENSTRÖM MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat blood cancer: experimental drug trial opens
Disease control Recruiting nowThis study is testing an oral drug called pacritinib for people with Waldenström macroglobulinemia, a rare blood cancer, that has come back or stopped responding to other treatments. The drug works by blocking specific proteins that help the cancer cells survive and grow. About 3…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC
-
New pill targets Tough-to-Treat blood cancers in major trial
Disease control Recruiting nowThis study is testing a new oral medication called BGB-16673 for people with various B-cell blood cancers that have come back or stopped responding to prior therapies. The main goals are to find a safe and effective dose and to see how well the drug shrinks tumors and controls th…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC